Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · IEX Real-Time Price · USD
27.60
+0.32 (1.17%)
May 31, 2024, 4:00 PM EDT - Market closed
Surgery Partners Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 44, with a low estimate of 35 and a high estimate of 51. The average target predicts an increase of 59.42% from the current stock price of 27.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SGRY stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $42 → $38 | Strong Buy | Maintains | $42 → $38 | +37.68% | May 8, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +81.16% | May 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +55.80% | Apr 10, 2024 |
| Barclays | Barclays | Hold Initiates $35 | Hold | Initiates | $35 | +26.81% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +55.80% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
3.12B
from 2.74B
Increased by 13.62%
Revenue Next Year
3.41B
from 3.12B
Increased by 9.37%
EPS This Year
1.09
from -0.09
EPS Next Year
1.31
from 1.09
Increased by 20.58%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.2B | 3.6B | 3.9B | 4.1B |
| Avg | 3.1B | 3.4B | 3.7B | 4.0B |
| Low | 3.0B | 3.2B | 3.5B | 3.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 17.6% | 14.2% | 14.6% | 11.3% |
| Avg | 13.6% | 9.4% | 9.3% | 8.1% |
| Low | 9.0% | 4.1% | 3.2% | 3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.21 | 1.50 | 1.83 | 2.07 |
| Avg | 1.09 | 1.31 | 1.66 | 2.01 |
| Low | 0.99 | 1.06 | 1.54 | 1.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 38.0% | 39.3% | 24.8% |
| Avg | - | 20.6% | 26.4% | 21.2% |
| Low | - | -2.7% | 17.3% | 16.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.